Cargando…
Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud
Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis (MDA5(+) DM) is an infrequent autoimmune disease, which mainly distributes in Asians and females. MDA5(+) DM usually presents various skin lesions and positive anti-MDA5 antibody (a myositis-specific autoantibody for i...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584642/ https://www.ncbi.nlm.nih.gov/pubmed/36275649 http://dx.doi.org/10.3389/fimmu.2022.1009546 |
_version_ | 1784813315018457088 |
---|---|
author | Yang, Jinming Yan, Bing |
author_facet | Yang, Jinming Yan, Bing |
author_sort | Yang, Jinming |
collection | PubMed |
description | Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis (MDA5(+) DM) is an infrequent autoimmune disease, which mainly distributes in Asians and females. MDA5(+) DM usually presents various skin lesions and positive anti-MDA5 antibody (a myositis-specific autoantibody for itself) with amyopathic or hypomyopathic features. For MDA5(+) DM patients, rapidly progressive interstitial lung disease is a common complication with a high-speed deterioration and a poor prognosis. Besides, there are other complications of MDA5(+) DM patients, including pneumomediastinum, macrophage activation syndrome and spontaneous intramuscular hemorrhage. These complications were rare but lethal, so it is necessary to explore their diagnosis methods, therapies and potential mechanisms, which are helpful for early diagnoses and timely treatment. To date, several cases and studies have shown distinctive features, diagnoses and treatments of these three rare complications, and there are also some differences among them. In this review, we outlined the characteristics, administration and potential pathogenesis of these rare complications of MDA5(+) DM. |
format | Online Article Text |
id | pubmed-9584642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95846422022-10-21 Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud Yang, Jinming Yan, Bing Front Immunol Immunology Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis (MDA5(+) DM) is an infrequent autoimmune disease, which mainly distributes in Asians and females. MDA5(+) DM usually presents various skin lesions and positive anti-MDA5 antibody (a myositis-specific autoantibody for itself) with amyopathic or hypomyopathic features. For MDA5(+) DM patients, rapidly progressive interstitial lung disease is a common complication with a high-speed deterioration and a poor prognosis. Besides, there are other complications of MDA5(+) DM patients, including pneumomediastinum, macrophage activation syndrome and spontaneous intramuscular hemorrhage. These complications were rare but lethal, so it is necessary to explore their diagnosis methods, therapies and potential mechanisms, which are helpful for early diagnoses and timely treatment. To date, several cases and studies have shown distinctive features, diagnoses and treatments of these three rare complications, and there are also some differences among them. In this review, we outlined the characteristics, administration and potential pathogenesis of these rare complications of MDA5(+) DM. Frontiers Media S.A. 2022-10-06 /pmc/articles/PMC9584642/ /pubmed/36275649 http://dx.doi.org/10.3389/fimmu.2022.1009546 Text en Copyright © 2022 Yang and Yan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Yang, Jinming Yan, Bing Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud |
title | Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud |
title_full | Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud |
title_fullStr | Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud |
title_full_unstemmed | Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud |
title_short | Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud |
title_sort | rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: time to nip them in the bud |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584642/ https://www.ncbi.nlm.nih.gov/pubmed/36275649 http://dx.doi.org/10.3389/fimmu.2022.1009546 |
work_keys_str_mv | AT yangjinming rarecomplicationsofantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositistimetoniptheminthebud AT yanbing rarecomplicationsofantimelanomadifferentiationassociatedgene5antibodypositivedermatomyositistimetoniptheminthebud |